SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Depotech(depo) -- Ignore unavailable to you. Want to Upgrade?


To: scott harrison who wrote (408)12/12/1997 1:34:00 PM
From: Czechsinthemail  Read Replies (2) | Respond to of 887
 
scott,
This is just one to wait out--or buy more if you can. The price drop is simply a reflection of reluctance to step up to the plate and buy ANYTHING while the tech market is so weak. The only hands parting with DEPO shares now are weak and timid ones. Any significant buying interest will significantly boost the stock price simply because there isn't much being offered. The real issue on this one is what to do after the news is out. My sense is that the combination of good DepoCyt news, validating the viability of the technology and future products, and the company's relative immunity to Asian market problems and possible economic slowdowns will combine to make this stock very attractive to funds. Some may be waiting out the approval just to make sure before jumping in on an incredible value.
Good luck to all.
Baird